baber/WOPTO huggingface dataset:
Patent NZ-573537-A (NZ)
Title: Locking mechanism for a sliding door with a deadbolt action
Inventor: SIEGLAAR EDWARD NORTON
IPC: E05B15/12
Filed: 2008-12-10
Abstract: A lock (100) for a siding door is disclosed. The lock (100) has a deadlock mode operable by a key from inside or outside, but may be locked and unlocked from the inside using a manual lever (160) when not deadlocked. The lock (100) has a housing (110) within which a latch linkage (120) moves between a locked position in which at least part of the latch linkage (120) extends from the housing (100) for engagement with a strike, and an unlocked position in which the latch linkage (120) is retracted into the housing (100). A locking assembly (130) with a moveable base member (140), a locking arrangement (150), an engaging member (170) and a manual lever (160) is also included. The base member (140) is coupled to the latch linkage (120) to move between a first position in which the latch linkage (120) is in a locked position, and a second position in which the latch linkage (120) is in its unlocked position. The locking arrangement (150) can be actuated for movement between a locking position when the base member (140) is in its first position, and in which the base member (140) is prevented from moving relative the housing (110), and a free position wherein the locking arrangement does not prevent movement of the base member (140). The manual lever (160), which is manually operable by a user, is associated with the base member (140). The lever (160) can move the base member (140) between its first position and second position, thereby moving the latch linkage (120) between its locked and unlocked position respectively. The engaging member (170) can be moved by at least one actuator, for example in the form of a key barrel (600); the engaging member (170) being associated with the base member (140) to move the base member (140) between its first position and second position, wherein relative movement between the engaging member (170) and the base member (140) is in a lost motion manner. The lost motion movement by the engaging member (170) is relative to the base member (140) between an engaged configuration, and an unengaged configuration. The engaging member (170) includes an actuating formation (190) which engages with the locking arrangement to actuate it to its locking position when the configuration of the base member (140) and the engaging member (170) is in an engaged configuration and the base member (140) is in its first position. This deadlocks the base member (140) against movement by operation of the manual lever (160).
Patent NZ-575135-A (NZ)
Title: Process to make cyclopropene complex compositions
Inventor: JACOBSON RICHARD MARTIN
IPC: B01J13/02
Filed: 2009-02-25
Abstract: Disclosed is a process for making a composition, wherein the composition comprises one or more cyclopropene complex, wherein the mole ratio of cyclopropene in said composition to molecular encapsulating agent in said composition is 0.92:1 or higher, wherein said process comprises the steps of (i) adding water, cyclopropene, and molecular encapsulating agent to a continuous reactor with residence time of 15 minutes or longer, (ii) removing material from said continuous reactor, wherein said material comprises water and cyclopropene complex, and (iii) subsequently removing water from said material to form said composition, wherein, after said step of removing water, the amount of water remaining in said composition is 0-10% by weight based on the weight of said composition. Also disclosed is the composition when made by the above process.
Patent NZ-578653-A (NZ)
Title: Personal computer power control method and device
Inventor: GELONESE GIUSEPPE ANTONIO
IPC: G06F1/32
Filed: 2007-12-27
Abstract: A method for controlling electrical power supply to a personal computer installation and an electrical power supply control device for a personal computer installation are disclosed. The electrical power supply control device includes a first controlled power outlet adapted for supplying electrical power to a plurality of first devices, software running on a personal computer adapted to monitor usage of at least one input device of the personal computer; software running on a personal computer adapted to monitor usage of at least one processor of the personal computer and software running on a personal computer adapted to monitor a power level mode of the personal computer. The power outlet being controlled by a first switch and the software is adapted to analyse the results of the monitoring to determine at least one power usage mode of the personal computer. The electrical power supply control device also includes a means adapted to control the first switch such that when the power usage mode is determined to be such that the first devices are not required to be powered, the first switch is operated to remove power from the first controlled power outlet.
Patent NZ-585737-A (NZ)
Title: Telescopic support apparatus for endless conveyor belt, typically for mining coal
Inventor: BREMHORST JOHN
IPC: B65G41/00
Filed: 2008-12-11
Abstract: An extendable support apparatus (200) for supporting an endless conveyor belt comprises an extendable frame (201), and a rest (220) for supporting the conveyor belt relative to the frame (201). The apparatus (200) is able to be extended and retracted by respectively extending and retracting the frame (201) while the conveyor belt circulates relative to the apparatus (200) and while the conveyor belt is supported by the rest (220). The extendable frame (201) is supported by a base frame (208) and the extendable frame (201) is constructed so that it may be sequentially extended or retracted.
Patent NZ-587600-A (NZ)
Title: An Intrautrerine System with polygonal frame surrounding elongate reservoir for extended release of stored medicament
Inventor: KORTESUO PIRJO
IPC: A61F6/14
Filed: 2009-04-01
Abstract: 587600 Disclosed is an intra-uterine system for a long-term insertion into a uterine cavity for dispensing a medicament. The intra-uterine system comprises a reservoir and a continuous, closed and flexible frame of polygonal shape, either triangular or pentagonal. The reservoir defines a substantially elongate chamber having two opposed ends. The chamber contains at least one therapeutically active substance, the reservoir being connected to the inner surface of the frame from one or both ends of the reservoir. The frame and the reservoir comprise a flexible polymer composition from siloxane based elastomer, thermoplastic polyurethane, thermoplastic polyurethane elastomer, EVA, polyethylene, thermoplastic polyurethane silicone elastomer or a mixture of at least two of them.
Patent NZ-589759-A (NZ)
Title: Diglycidic ether derivative therapeutics and methods for their use
Inventor: SADAR MARIANNE D
IPC: A61P5/28
Filed: 2009-07-02
Abstract: This disclosure provides compound having a structure of Formula I or Formula II. Uses of such compounds for treatment of various indications, including prostate cancer, breast cancer, ovarian cancer, endometrial cancer, hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty, and age-related macular degeneration as well as methods of treatment involving such compounds are also provided.
Patent NZ-589950-A (NZ)
Title: A tissue rectactor for treatment of a breathign disorder and providing an electrical stimulus
Inventor: SANDERS IRA
IPC: A61F5/56
Filed: 2005-02-28
Abstract: Disclosed is a tissue retractor for treatment of a breathing disorder and providing an electrical stimulus. The retractor includes a shaft sized and configured for transmucosal insertion into a soft tissue located in a patient's oral cavity or pharynx; a retractor member connection at or near a first end of the shaft and an anchor member connected at or near a second end of the shaft. The tissue retractor also includes an electrode configured to provide an electrical stimulus to cause contraction of the soft tissue. The retractor member or the anchor member is configured to be positioned on an external surface of the soft tissue. Neither the retractor member nor the anchor member are configured to be tethered to bone.
Patent NZ-595294-A (NZ)
Title: Intraocular sustained release drug delivery systems and methods for treating ocular conditions
Inventor: BURKE JAMES A
IPC: A61K9/00
Filed: 2010-03-25
Abstract: 595294 Disclosed herein is a pharmaceutical composition comprising a plurality of sustained release biodegradable microspheres having a diameter between about 30 and about 100 microns, the microspheres comprising from about 10 to about 30 weight percent an anti-hypertensive agent, such as latanoprost, bimatoprost or travoprost, and from about 70 to about 90 weight % a biodegradable polymer, such as a polylactic polyglycolic copolymer (PLGA) and/or a poly lactic acid polymer (PLA), wherein the microspheres release therapeutically effective amounts of the anti-hypertensive agent for a period of time between about 10 days and about 120 days. Additionally disclosed is the use of said composition for treating elevated intraocular pressure comprise the step of intracameral administration of the medicament to a patient with elevated intraocular pressure.
Patent NZ-597301-A (NZ)
Title: Evaporator defrost cycle with concurrent refrigeration
Inventor: ISLAM RAFIQUL
IPC: F25B47/02
Filed: 2011-12-21
Abstract: Disclosed is an evaporator defrost system in a refrigeration system including an insulated refrigeration cabinet. The defrost system includes an evaporator within the cabinet. The evaporator has a refrigeration mode for cooling air and a defrost mode. The defrost system also includes control means for controlling the flow of high pressure liquid refrigerant gas to an inlet side of the evaporator, means for circulation of air through the evaporator to a product storage space within the cabinet, means associated with the evaporator to control suction pressure to a compressor via an outlet line from the evaporator, and sensing means to determine when a refrigeration temperature has reached a predetermined level. The defrost system includes means for maintaining at least partial but continuous refrigeration during a defrost cycle. The at least partial refrigeration of the evaporator is maintained by refrigerant flow through the evaporator. The means for providing at least partial continuous refrigeration comprises means to control that rate at which gas is removed from the evaporator during the at least partial refrigeration.
Patent NZ-599356-A (NZ)
Title: Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
Inventor: O DONNELL MICHAEL
IPC: C07D475/00
Filed: 2010-09-24
Abstract: A method of preparing a compound represented by structural formula (I), or a pharmaceutically acceptable salt thereof is disclosed, wherein the variables of structural formula (I) are as described in the specification and claims, wherein the method comprises the steps of: (a) reacting a compound represented by structural formula (A) with HNR1R7 under suitable conditions to form a compound represented by structural formula (B); and (b) (i) when R12 is -NO2, and R11 is -OR14: (1) cyclizing the compound represented by structural formula (B) under suitable cyclisation conditions to form a compound represented by structural formula (II); and (2) optionally reacting the compound represented by structural formula (II) with R9-LG2, wherein LG2 is a suitable leaving group, to form the compound represented by structural formula (I), wherein R8 is R9; or (ii) when R12 is halogen, and R11 is -NHR13: (1) cyclizing the compound represented by structural formula (B) under suitable cyclisation conditions to form the compound represented by structural formula (I); and (2) optionally, when R13 is - H, reacting the compound produced from step (b), (ii), (1) with R9-LG2, wherein LG2 is a suitable leaving group, to form the compound represented by structural formula (I) wherein R8 is R9 and not -H. These compounds are useful as protein kinase inhibitors, such as Polo-like kinases (Plk1, Plk2, Plk3, and/or Plk4) inhibitors, and are suitable for the treatment of diseases, disorders, and conditions characterized by excessive or abnormal cell proliferation (particularly tumour cell proliferation), which are selected from autoimmune diseases, inflammatory diseases, proliferative and hyper-proliferative diseases (particularly cancer), immunologically-mediated diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cardiovascular diseases, hormone related diseases, allergies, asthma, and Alzheimer's disease.
Patent NZ-600631-A (NZ)
Title: Heteroaryl compounds and uses thereof
Inventor: MAZDIYASNI HORMOZ
IPC: C07D487/18
Filed: 2010-12-29
Abstract: Disclosed herein are pyrimidine substituted compounds of general formula I-b, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of protein kinase, particularly BTK, JAK3 and TEC-kinase and as such are useful in the treatment of autoimmune disease, heretoimmune disease, inflammatory disease, cancer, disease of the bone and joints, a thromboembolic disorder, a neurodegenerative disorder, or a solid or hematologic malignancy.
Patent NZ-611668-A (NZ)
Title: Method for interplanting energy crops
Inventor: LEIST JAMES R
IPC: A01G23/02
Filed: 2011-12-07
Abstract: NZ 611668 Disclosed is a method for interplanting a primary crop and an energy crop on a plantation site, the method comprising the steps of: planting the primary crop in a first row and in a second row, the first row and the second row being separated by an intermediate area, the intermediate area being divided into a centre portion, a first side portion, and a second side portion; preparing the plantation site for planting the energy crop by: (a) lifting a soil and plantation debris mixture from the intermediate area, the soil and plantation debris mixture comprising a soil component and a plantation debris component; (b) redepositing the soil component onto the intermediate area primarily into the centre portion; and (c) redepositing the plantation debris component onto the intermediate area primarily into the first side portion and/or the second side portion; and planting the energy crop in the intermediate area. Also described is a method of preparing a plantation site for planting an energy crop as disclosed in the specification.
Patent NZ-622814-A (NZ)
Title: Recording, tracking and evaluating system
Inventor: CIRIANNI GIUSEPPE
IPC: G06Q50/08
Filed: 2012-08-23
Abstract: Disclosed is a system for recording, tracking and evaluating for project control. The system comprises a first input (10), a secondary input (15), a determinator (20) and an automatic notificator (30). The first input (10) receives a plurality of input data to define details of at least part of a project including a predetermined level of completion of the at least part of a project. The secondary input (15) receives real time data related to the at least part of a project. The determinator (20) has a processor means with a receiver for receiving digital input from the secondary input (15) and with a comparator for comparing and sending determined comparison of the real time data of the secondary input (15) with the input data of the first input (10) in order to assess the at least part of a project and the gradual completion of the at least part of a project to the predetermined level of completion of the at least part of the project. The automatic notificator (30) has a receiver for receiving the determined comparison from the determinator (20) and automatically and selectively initiating communication over a communication system that sends output to one or more users defined in the input data according to the determinator (20) assessment of completion to the predetermined level of the at least part of a project to the predetermined level according to the project. Wherein the at least part of the project assessed by the determinator (20) provides automatic real-time control according to the defined at least part of a project by the input data of the first input (10) defining the characteristics of a plurality of subprojects according to schedule, tasks, people and time and the at least two of the subprojects to be undertaken are at least partially concurrent and the secondary input (15) receiving real time data related to the at least part of a project and instigates the automatic notificator (30) to sending output signals to the identified people in the input data to begin the next at least part of a project to the predetermined level according to the project.
Patent NZ-701278-A (NZ)
Title: Human antibodies and specific binding sequences thereof for use in stroke and ischemia or ischemic conditions
Inventor: RODRIGUEZ MOSES
IPC: A61K39/395
Filed: 2013-04-17
Abstract: Specific binding members, particularly human antibodies, particularly recombinant antibodies, and fragments thereof, which are capable of binding to and recognizing neurons in the CNS and eliciting responses in CNS neurons are provided. The antibodies are useful in the diagnosis and treatment of conditions associated with nerve damage, injury or degeneration and neurodegenerative disease, and in particular in the treatment or alleviation of stroke or cerebral ischemia. The antibodies, variable regions or CDR domain sequences. thereof, and fragments thereof of the invention may also be used in therapy in combination with chemotherapeutics, immune modulators, or neuroactive agents and/or with other antibodies or fragments thereof. The antibodies or active fragments thereof may be used in therapy for stroke or cerebral ischemia alone or in combination with thrombolytics such as TPA. Antibodies are exemplified by the antibodies lgM12 and lgM42 whose sequences are provided herein.
Patent NZ-707757-A (NZ)
Title: Slurry distributor with a profiling mechanism, system, and method for using same
Inventor: WITTBOLD JAMES
IPC: B28B19/00
Filed: 2013-10-21
Abstract: In order to help spread increasingly-viscous gypsum slurries on a forming table in the production of gypsum products, a slurry distributor includes a distribution conduit and a profiling mechanism. The distribution conduit extends generally along a longitudinal axis and includes an entry portion and a distribution outlet in fluid communication with the entry portion. The distribution outlet includes an outlet opening having a width, along a transverse axis, and a height, along a vertical axis which are both mutually perpendicular to the longitudinal axis. The profiling mechanism includes a profiling member in contacting relationship with the distribution conduit. The profiling member is translatable along the vertical axis and rotatable about a pivot axis that is substantially parallel to the longitudinal axis. The profiling member is rotatable about the pivot axis over an arc length such that the profiling member is in a range of positions over which the profiling member is in variable compressive engagement with the portion of the distribution conduit across the transverse axis such that the height of the outlet opening varies along the transverse axis so as to alter the flow pattern of slurry being discharged from the outlet opening to help provide an increased spread angle relative to the machine direction of the forming table.
Patent NZ-719474-A (NZ)
Title: Method to use gene expression to determine likelihood of clinical outcome of renal cancer
Inventor: SHAK STEVEN
IPC: G06F19/00
Filed: 2011-01-07
Abstract: Disclosed is a method for determining a likelihood of recurrence of renal cell carcinoma for a patient with renal cell carcinoma comprising: (a) measuring, in a biological sample obtained from the patient, an expression level of an RNA transcript of NOS3; (b) normalizing the expression level of the RNA transcript of NOS3 to obtain a normalized NOS3 expression level; and (c) determining a likelihood of recurrence of renal cell carcinoma for the patient based on the normalized NOS3 expression level, wherein increased normalized NOS3 expression level is positively correlated with likelihood of recurrence of renal cell carcinoma. Further disclosed are methods of determining an increased tumour stage or tumour grade according to an increased normalized NOS3 expression level is positively correlated with increase grade or stage of the tumour. Further disclosed are methods of determining presence of necrosis in a renal carcinoma sample obtained from a patient with renal cell carcinoma according to an increased normalized NOS3 expression level is positively correlated with the presence of necrosis.
Patent NZ-721495-A (NZ)
Title: Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
Inventor: GREINWALD ROLAND
IPC: A61K9/00
Filed: 2014-12-18
Abstract: Disclosed is an optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus. Said pharmaceutical formulation in the form of an orodispersible effervescent tablet is stable, easy to produce, and can be used without dissolving same in a liquid. It is not necessary to drink anything with the tablet as this would reduce the time that the budesonide solution remains in the affected regions of the esophagus. The effervescent tablet of the invention surprisingly resulted in an unexpectedly high rate of histological remission in patients with active eosinophilic esophagitis.
Patent NZ-748471-A (NZ)
Title: Automatical in situ control of the confined environment of metabolically active produce
Inventor: VERBOVEN PIETER
IPC: A23B7/148
Filed: 2017-05-18
Abstract: A control system for controlling the storage of metabolically active produce in a defined confined environment, said control system comprising at least one gas analyzing and one pressure measurement means comprising a control unit for determining an adjusted gas medium composition of the confined environment for protecting the produce against metabolic degradation; at least one operating/actuating means for adapting the gas medium in the confined storage environment based on said determined adjusted gas medium composition; wherein the control unit is adapted for determining the adjusted gas medium composition based on a mathematical model of the system that determines a metabolic coefficient of the produce by combining measured, changes of gas composition in the confined environment with dynamic pressure changes in the confined space. The value of the metabolic coefficient is used as input for a control algorithm to continuously adjust the gas composition in the confined space in response to the metabolic activity of the produce.
Patent NZ-748746-A (NZ)
Title: Pyrazolopyrimidine derivatives as kinase inhibitor
Inventor: HAN MI RYEONG
IPC: A61K31/519
Filed: 2017-06-30
Abstract: The present invention relates to a pyrazolopyrirmidine derivative represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
Patent NZ-757128-A (NZ)
Title: Optical system for warning light
Inventor: SMITH TODD
IPC: B60Q1/52
Filed: 2018-03-13
Abstract: Commercially available LED’s have undesirable spatial radiation patterns for some applications, being directional light sources. This invention provides an optical element that redirects the light emitted from an LED into a vertically collimated, horizontally dispersed beam of light visible over a range of viewing angles. The invention includes an LED optical assembly including an LED, a lens, and a reflector. The lens is made up of a light entry surface and a light emission surface rotated about a rotational axis. The reflector has a pair of first reflecting surfaces and a pair of second reflecting surfaces. The first reflecting surfaces are defined by a first curve rotated about the rotational axis. The second reflecting surfaces are defined by a second curve projected along the rotational axis. The lens and reflector cooperate to redirect light emitted by the LED into a vertically collimated wide angle beam of light.